Posted in colon cancer

There is a clear link between taking antibiotics and an increased risk of developing colon cancer within the next five to ten years. This has been confirmed by researchers at Umeå University, Sweden, after a study of 40,000 cancer cases. The impact of antibiotics on the intestinal microbiome is thought to lie behind the increased risk of cancer. "The results underline the fact that there are many reasons to be restrictive with antibiotics. While in many cases antibiotic therapy is...

Vitamin D has been identified as a potential protective factor in the development of colorectal cancer (CRC). We expect to see a stronger association of ultraviolet B (UVB) exposure and CRC with increasing age since chronic vitamin D deficiency leads to sustained molecular changes that increase cancer risk. The DINOMIT (disjunction, initiation, natural selection, overgrowth, metastasis, involution, and transition) model postulates various stages of cancer development due to vitamin D de...

Colorectal cancer (CRC) is the third most common cancer and one of the main causes of cancer death entire the world. Environmental, dietary, and lifestyle factors including red meat consumption, cigarette smoking, alcohol intake and family history are the most important risk factors of CRC. Multiple pathways including inflammation, oxidative stress, and apoptosis are involved in its incidence and progression. Resveratrol, a polyphenolic compound, has different pharmacologic functions in...

Inflammasone has a relationship with obesity-related colon cancer. According to recent evidence-based research, dysregulation of inflammasomes could be a significant factor in the development of obesity-associated colon cancer. When this part of the innate immune system, which provides the first line of defence against pathogens, is exposed to prolonged inflammation from visceral adipose tissue (VAT), it increases the risk of obesity-related colon cancer.
Dysregulation of inflammasomes wit...

Bowel cancer survival rates could be improved if chemotherapy drugs were delivered via tiny nanoparticles directly to tumours instead of being taken orally. This is the finding, published in the journal Carbohydrate Polymers, of an Indian and Australian study that used nanoparticles to target bowel cancer, the third-most common cancer. In animal experiments researchers found nanoparticles containing the chemotherapy drug Capecitabine attach themselves directly to the diseased cells, bypassi...